Statin Eligibility in Primary Prevention: From a Risk-Based Strategy to a Personalized Approach Based on the Predicted Benefit (2018)
- Authors:
- Autor USP: BITTENCOURT, MÁRCIO SOMMER - HU
- Unidade: HU
- DOI: 10.1016/j.amjcard.2018.02.011
- Subjects: DOENÇAS CARDIOVASCULARES; FATORES DE RISCO; FÁRMACOS; COLESTEROL
- Language: Inglês
- Imprenta:
- Source:
- Título: American journal of cardiology
- ISSN: 0002-9149
- Volume/Número/Paginação/Ano: v. 121, n. 11, p. 1315-1320, 2018
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
CESENA, Fernando H. Y. e SANTOS, Raul D. Statin Eligibility in Primary Prevention: From a Risk-Based Strategy to a Personalized Approach Based on the Predicted Benefit. American journal of cardiology, v. 121, n. 11, p. 1315-1320, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.amjcard.2018.02.011. Acesso em: 10 fev. 2026. -
APA
Cesena, F. H. Y., & Santos, R. D. (2018). Statin Eligibility in Primary Prevention: From a Risk-Based Strategy to a Personalized Approach Based on the Predicted Benefit. American journal of cardiology, 121( 11), 1315-1320. doi:10.1016/j.amjcard.2018.02.011 -
NLM
Cesena FHY, Santos RD. Statin Eligibility in Primary Prevention: From a Risk-Based Strategy to a Personalized Approach Based on the Predicted Benefit [Internet]. American journal of cardiology. 2018 ; 121( 11): 1315-1320.[citado 2026 fev. 10 ] Available from: https://doi.org/10.1016/j.amjcard.2018.02.011 -
Vancouver
Cesena FHY, Santos RD. Statin Eligibility in Primary Prevention: From a Risk-Based Strategy to a Personalized Approach Based on the Predicted Benefit [Internet]. American journal of cardiology. 2018 ; 121( 11): 1315-1320.[citado 2026 fev. 10 ] Available from: https://doi.org/10.1016/j.amjcard.2018.02.011 - Heart disease and stroke statistics-2019 update: a report From the American Heart Association
- The yield of downstream tests after exercise treadmill testing: a prospective cohort study
- Coronary calcium score vs. computed tomography angiography as tools to stratify cardiovascular risk
- Implications of coronary artery calcium testing on risk stratification for lipid-lowering therapy according to the 2016 European Society of Cardiology recommendations: The MESA study
- Statin eligibility in primary prevention: from a risk-based strategy to a personalized approach based on the predicted benefit
- Impact of coronary remodeling on fractional flow reserve [letter]
- Percent reduction or target-based strategies to manage blood cholesterol in subjects at intermediate risk: cardiovascular benefit versus diabetes onset risk in real world patients
- Implications of coronary artery calcium testing among statin candidates according to American College of Cardiology/American Heart Association Cholesterol Management Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis)
- Anomalous origin of the coronary artery arising from the opposite sinus: prevalence and outcomes in patients undergoing coronary CTA
- Multimodality imaging of an adult with Shone complex
Informações sobre o DOI: 10.1016/j.amjcard.2018.02.011 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
